Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
crispr
8
×
tc
bio
editas medicine
health
jennifer doudna
american biochemists
berkeley college of chemistry faculty
biology
biotechnology
crystallographers
emerging technologies
harvard university alumni
howard hughes medical investigators
living people
members of the united states national academy of sciences
molecular biology
non-coding rna
repetitive dna sequences
university of california
yale department of molecular biophysics & biochemistry faculty
1963 births
american women scientists
biological engineering
column
engineering disciplines
enzymes
genetic engineering
members of the national academy of medicine
science
women biochemists
1987 establishments in texas
23andme
agriculture
annual events in texas
applied genetics
bill gates
bioethics
broad institute
cancer
What
read
8
×
crispr
editing
gene
doudna
jennifer
cas
technology
berkeley’s
institute
inventor
patent
today
berkeley
biotech
century
charpentier
colleague
discovery
emmanuelle
future
genes
genetic
going
max
public
rights
stage
think
ability
actually
advances
afternoon
ambitious
andme
applications
argument
arguments
awards
begin
Language
Current search:
crispr
×
read
×
@techcrunch.com
7 years ago
CRISPR pioneer Jennifer Doudna shines hope on the future of genetic modification at SXSW
@techcrunch.com
7 years ago
CRISPR-Cas9 inventor Jennifer Doudna’s plans on moving forward, genetically modifying humans
@techcrunch.com
7 years ago
Oral arguments for who owns CRISPR-Cas9 starts next month
@techcrunch.com
7 years ago
CRISPR will have to wait for that Nobel prize
@techcrunch.com
7 years ago
Jennifer Doudna, inventor of gene editing technology CRISPR Cas9, is coming to Disrupt
@techcrunch.com
7 years ago
Reshaping human health and changing lives through gene editing
@techcrunch.com
8 years ago
Innovation in genomics and the future of medtech
@techcrunch.com
8 years ago
Editas biotech stock drops by 26% over CRISPR patent dispute